BioTelemetry provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing, and centralized core laboratory services for clinical research. The Company operates in three segments: Healthcare, Research, and Technology. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. BioTelemetry offers cardiologists and electrophysiologists a full spectrum of solutions which provides them with a single source of cardiac monitoring services. These services range from the differentiated mobile cardiac telemetry service to the wireless and trans-telephonic event, traditional Holter, extended-wear Holter, Pacemaker and International Normalized Ratio monitoring. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The Technology segment focuses on the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals.

Show more
Malvern, US
Size (employees)
1,087 (est)+16%
BioTelemetry was founded in 2013 and is headquartered in Malvern, US
Report incorrect company information

Key People/Management at BioTelemetry

Joseph H. Capper

Joseph H. Capper

President and Chief Executive Officer
Heather Getz CPA

Heather Getz CPA

Executive Vice President and Chief Financial Officer
Peter Ferola

Peter Ferola

General Counsel and Senior Vice President
Wayne M. Derkac M.D

Wayne M. Derkac M.D

Vice President, Medical Affairs
Tim Raher

Tim Raher

Senior Vice President, Human Resources

BioTelemetry Office Locations

BioTelemetry has offices in Eagan, San Diego, Chiyoda-ku, London and in 8 other locations
Malvern, US (HQ)
102 1000 Cedar Hollow Rd
Chester County, US
Beacon Light Rd
Eagan, US
150 1285 Corporate Center Dr
Eagan, US
175 1285 Corporate Center Dr
Norfolk, US
204 5700 Lake Wright Dr
Phoenix, US
100 2750 S 18th Pl
Show all (13)
Report incorrect company information

BioTelemetry Financials and Metrics

BioTelemetry Financials

BioTelemetry's revenue was reported to be $286.78 m in FY, 2017

Revenue (Q1, 2018)

94.5 m

Gross profit (Q1, 2018)

58 m

Gross profit margin (Q1, 2018), %


Net income (Q1, 2018)

5 m

EBIT (Q1, 2018)

6.7 m

Market capitalization (14-Jun-2018)

1.5 b

Closing share price (14-Jun-2018)


Cash (31-Mar-2018)

36.3 m


1.6 b
BioTelemetry's current market capitalization is $1.5 b.
usdFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


119 m111.5 m129.5 m166.6 m178.5 m208.3 m286.8 m

Revenue growth, %


Cost of goods sold

6.2 m5.1 m4.9 m73.1 m72 m78.9 m114.4 m

Gross profit

112.8 m106.4 m124.6 m93.5 m106.6 m129.5 m172.4 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018


31.9 m37.2 m42.7 m43.1 m43.4 m44.8 m43.5 m48.6 m52.7 m53.1 m55.9 m58.1 m94.5 m

Cost of goods sold

12.6 m15.5 m19 m19.4 m18.2 m18.1 m17.2 m18 m19.8 m20.2 m23 m22.2 m36.4 m

Gross profit

19.2 m21.6 m23.6 m23.7 m25.2 m26.7 m26.3 m30.6 m32.9 m32.9 m32.9 m36 m58 m

Gross profit Margin, %

usdY, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016FY, 2017


18.7 m18.3 m18.3 m22.2 m20 m19 m23.1 m36 m

Accounts Receivable


2.4 m2.4 m1.5 m5.2 m5.3 m

Current Assets

44.3 m49.5 m47 m59.6 m90.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018


21 m12 m13.5 m12.2 m12.3 m14.8 m15.5 m22.8 m25.4 m32.3 m25.1 m26.9 m36.3 m


3.4 m3 m3 m2.6 m3 m3.2 m2.8 m2.9 m3.5 m3.8 m4.3 m4.1 m6.4 m

Current Assets

46 m40.8 m41.8 m41.9 m42.3 m43.5 m45.2 m51.7 m59 m68.3 m64 m65.9 m98.4 m


17.7 m25 m29.1 m29 m21.4 m23.8 m25 m26.3 m26.3 m26.3 m26.4 m26.7 m
usdFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(7.3 m)(9.8 m)7.4 m53.4 m(17.1 m)

Depreciation and Amortization

12.3 m12.6 m12.5 m14.3 m18.3 m


340 k299 k188 k(753 k)665 k

Accounts Payable

2.4 m47 k(4.7 m)3.1 m(9.6 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Net Income

(7.3 m)(4.1 m)(8.1 m)(8.1 m)(69 k)2.1 m4.6 m4 m8.3 m12.4 m196 k1.9 m5 m

Depreciation and Amortization

9.5 m2.8 m6 m9.2 m3 m6 m9.1 m3.3 m6.9 m10.6 m3.7 m7.5 m9.8 m


(520 k)(104 k)(104 k)307 k(456 k)(640 k)(241 k)(487 k)(786 k)(1.2 m)810 k845 k(1 m)

Accounts Payable

2 m1.8 m1.3 m(402 k)(1.2 m)(1.2 m)(2.7 m)1.9 m1.8 m934 k463 k(3.2 m)2.3 m
USDY, 2018


242.4 x


179.9 x

Financial Leverage

2.1 x
Show all financial metrics

BioTelemetry Operating Metrics

FY, 2015FY, 2016

Patents (US)

34 49

Patents (foreign)

81 111

Patents Issued

115 160


17 22
Show all operating metrics
Report incorrect company information

BioTelemetry Online and Social Media Presence

Embed Graph
Report incorrect company information

BioTelemetry News and Updates

US Ambulatory (ECG) Industry Business & Investment Opportunity (2018 – 2022) Market Research Reports 2022

Pune, India, 1st May 2018: WiseGuyReports announced addition of new report, titled “US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018-2022)”. Posted via Industry Today. Follow us on Twitter @IndustryToday

Latest News on - Prescribed Health Apps Global Market Trends & Opportunities

Wiseguyreports.Com Publish New Market Research Report On -“Prescribed Health Apps 2017 Global Market – Key Players, Size, Trends, Opportunities, Growth- Analysis to 2021” Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information